公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2017 | Laparoendoscopic single-site adrenalectomy in patients with primary hyperaldosteronism: A prospective study with long-term follow up | Hu Y.-H.; Wu C.-H.; Er L.-K.; Lin C.D.; Liu Y.-B.; SHIH-CHIEH CHUEH ; Tsai Y.-C. | Asian Journal of Surgery | 1 | 1 | |
2016 | Long term outcome of Aldosteronism after target treatments | VIN-CENT WU ; SHUO-MENG WANG ; Chang C.-H.; Hu Y.-H.; LIAN-YU LIN ; YEN-HUNG LIN ; SHIH-CHIEH CHUEH ; Chen L.; KWAN-DUN WU | Scientific Reports | 115 | 98 | |
2009 | Mesothelin inhibits paclitaxel-induced apoptosis through the PI3K pathway | Chang M.-C.; CHI-AN CHEN ; CHANG-YAO HSIEH ; CHIEN-NAN LEE ; Su Y.-N.; Hu Y.-H.; WEN-FANG CHENG | Biochemical Journal | 57 | 55 | |
2021 | Natural Language Processing Enhances Prediction of Functional Outcome After Acute Ischemic Stroke | Sung S.-F.; CHIH-HAO CHEN ; Pan R.-C.; Hu Y.-H.; JIANN-SHING JENG | Journal of the American Heart Association | 11 | 11 | |
2015 | Pincer nail deformity as the main manifestation of Clouston syndrome | Hu Y.-H.; Lin Y.-C.; WUH-LIANG HWU ; Lee Y.-M. | British Journal of Dermatology | 7 | 7 | |
2017 | The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes | VIN-CENT WU ; SHUO-MENG WANG ; SHIH-CHIEH CHUEH ; SHAO-YU YANG ; KUO-HOW HUANG ; YEN-HUNG LIN ; Connolly R.; Hu Y.-H.; Gomez-Sanchez C.E.; Peng K.-Y.; KWAN-DUN WU | Scientific Reports | 70 | 47 | |
2019 | Primary aldosteronism and obstructive sleep apnea a cross-sectional multi-ethnic study | Buffolo F.; Li Q.; Monticone S.; Heinrich D.A.; Mattei A.; Pieroni J.; Mei M.; Yang S.; Hu Y.-H.; Yang M.-C.; Sabbadin C.; Pizzolo F.; Giacchetti G.; Fallo F.; Veglio F.; Reincke M.; VIN-CENT WU ; Mulatero P. | Hypertension | 42 | 32 | |
2017 | Risk of new-onset diabetes mellitus in primary aldosteronism: A population study over 5 years | VIN-CENT WU ; SHIH-CHIEH CHUEH ; Chen L.; Chang C.-H.; Hu Y.-H.; YEN-HUNG LIN ; KWAN-DUN WU ; WEI-SHIUNG YANG | Journal of Hypertension | 89 | 75 | |
2018 | Risk of sepsis in patients with primary aldosteronism | CHIEH-KAI CHAN ; Hu Y.-H.; Chen L.; CHIN-CHEN CHANG ; YU-FENG LIN ; TAI-SHUAN LAI ; KUO-HOW HUANG ; YEN-HUNG LIN ; VIN-CENT WU ; KWAN-DUN WU ; Lin J.-H.; Wang W.-J.; Wu C.-H.; Chang C.-H.; Chang Y.-L.; Tsai Y.-C.; Yu C.-C.; Chang H.-W.; LIAN-YU LIN ; Hu F.-C.; SHUO-MENG WANG ; Shih-Cheng Liao ; CHING-CHU LU ; RUOH-FANG YEN | Critical Care | 8 | 6 | |
2021 | Taiwan mini-frontier of primary aldosteronism: Updating treatment and comorbidities detection | CHIEH-KAI CHAN ; Chang, Yi-Yao; Tsai, Yi-Chun; ZHENG-WEI CHEN ; Wu, Chun-Yi; Huang, Wei-Chieh; Yen, I-Weng; Wu, Kuo-Hsin; VIN-CENT WU ; YEN-HUNG LIN ; SHUO-MENG WANG ; Wang W.-J.; Wu C.-H.; Hu Y.-H.; Er L.K.; Chang C.-H.; Tsai Y.-C.; Yu C.-C.; LIAN-YU LIN ; Hu F.-C.; CHIN-CHEN CHANG ; KAO-LANG LIU ; Wang S.-M.; KUO-HOW HUANG ; SHIH-CHIEH CHUEH ; SHIH-CHENG LIAO ; CHING-CHU LU ; RUOH-FANG YEN ; KWAN-DUN WU ; TAIPAI Study Group | Journal of the Formosan Medical Association = Taiwan yi zhi | 4 | 3 | |
2019 | Targeted treatment of primary aldosteronism – The consensus of Taiwan Society of Aldosteronism | KUO-HOW HUANG ; Yu C.-C.; Hu Y.-H.; CHIN-CHEN CHANG ; CHIEH-KAI CHAN ; Shih-Cheng Liao ; Tsai Y.-C.; SHIH-CHIEH CHUEH ; VIN-CENT WU ; YEN-HUNG LIN ; Lin J.-H.; Wang W.-J.; Wu C.-H.; Er L.-K.; Chang C.-H.; Chang Y.-L.; YI-LWUN HO ; Chang H.-W.; LIAN-YU LIN ; Hu F.-C.; KAO-LANG LIU ; SHUO-MENG WANG ; CHING-CHU LU ; RUOH-FANG YEN ; KWAN-DUN WU ; TAIPAI, Taiwan Primary Aldosteronism Investigator | Journal of the Formosan Medical Association | 21 | 18 | |
2013 | Twenty-four-hour urinary aldosterone predicts inappropriate left ventricular mass index in patients with primary aldosteronism | CHI-SHENG HUNG ; YI-LWUN HO ; Chang Y.-Y.; VIN-CENT WU ; Wu X.-M.; JEN-KUANG LEE ; SHIH-CHIEH CHUEH ; YEN-HUNG LIN ; Changh Y.-S.; SHAO-YU YANG ; Hu Y.-H.; Sui M.-J.; MING-FONG CHEN ; KWAN-DUN WU | The Scientific World Journal | 18 | 18 |